Complement C3 testing Kit
- UID
- MFG/IVD/2022/000117_7c4663511051e5d44aa741a8f6ce80db_b960fb535eb70478bc366f0454a99110
- Device class
- Class B
- Brand name
- Cellpro
- License holder
- Cellpro Systems Private Limited
- Approving authority
- Haryana
- Product information
- C3c is the central component of classical and alternative pathways of thecomplement activation, and between these pathways and the membrane attack complex. After the activation, the products of the degradation of C3 have important biological functions. C3b is involved in immunology bonds. C3a acts as an anaphylatoxin (Cellpro) and chemotaxin, recruiting phagocytes into the area of release. C3 increases as an acute phase protein, induced by Interleukin 1 (Cellpro), IL-6 and TNF (Cellpro); so an increased level could be seen in the acute inflammatory reactions. An increased level is present in biliary obstruction and in elevated percentage of patients with Focal Glomerulosclerosis. C3 decreased levels happens for genetic deficiency or for acquired deficiency and normally gives severe disease as immunological infections due to bacteria and poststreptococcal glomerulo-nephrities
Complement C3 testing Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000117_7c4663511051e5d44aa741a8f6ce80db_b960fb535eb70478bc366f0454a99110. This device is marketed under the brand name Cellpro. The license holder is Cellpro Systems Private Limited, and it is classified as Device Class Class B. The approving authority is Haryana.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.